Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET
- 11 March 2015
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 23 (9) , 813-820
Abstract
Background: High expression of glucagon-like peptide-1 receptor (GLP-1R) in insulinoma supplies a potential drug target for tumor imaging. Exendin-4 can specifically bind to GLP-1R as an agonist and its analogs are extensively used in receptor imaging studies. Purpose: A new GLP-1R imaging agent, [18F]AlF-NOTA-MAL-Cys39-exendin-4, was designed and prepared for insulinoma imaging. Methods: Cys39-exendin-4 was conjugated with NOTA-MAL, then the compound was radiolabeled with [18F]AlF complex to obtained [18F]AlF-NOTA-MAL-Cys39-exendin-4. The tumor-targeting characters of the tracer were evaluated in INS-1 cells and BALB/c nude mice models. Results: [18F]AlF-NOTA-MAL-Cys39-exendin-4 can be efficiently produced with a yield of 17.5 ± 3.2% (non-decay corrected) and radiochemical purity of >95%. The IC50 value of displacement [18F]AlF-NOTA-MAL-Cys39-exendin-4 with Cys39-exendin-4 was 13.52 ± 1.36 nM. PET images showed excellent tumor visualization with high uptake (9.15 ± 1.6%ID/g at 30 min and 7.74 ± 0.87%ID/g at 60 min). The tumor to muscle, pancreas and liver ratios were 63.25, 3.85 and 7.29 at 60 min after injection. GLP-1R binding specificity was demonstrated by co-injection with an excess of unlabeled Cys39-exendin-4 and the tumor uptake was found to be reduced significantly. Conclusion: [18F]AlF-NOTA-MAL-Cys39-exendin-4 shows favorable characteristics for insulinoma imaging and may be translated to clinical studies.Keywords
This publication has 29 references indexed in Scilit:
- First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid RadiofluorinationJournal of Nuclear Medicine, 2013
- Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in InsulinomaTheranostics, 2012
- 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Comparison Study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET Imaging of U87MG Tumors in MiceBioconjugate Chemistry, 2011
- PET of Insulinoma Using 18F-FBEM-EM3106B, a New GLP-1 AnalogueMolecular Pharmaceutics, 2011
- 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptidesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Neuroendocrine Tumors of the PancreasThe Oncologist, 2009
- Localization of Insulinomas to Regions of the Pancreas by Intraarterial Calcium Stimulation: The NIH ExperienceThe Journal of Clinical Endocrinology & Metabolism, 2009